CEOP-R regimen

WikiDoc Resources for CEOP-R regimen
Articles
Most recent articles on CEOP-R regimen Most cited articles on CEOP-R regimen Review articles on CEOP-R regimen Articles on CEOP-R regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on CEOP-R regimen Images of CEOP-R regimen Photos of CEOP-R regimen Podcasts & MP3s on CEOP-R regimen Videos on CEOP-R regimen
Evidence Based Medicine
Cochrane Collaboration on CEOP-R regimen Bandolier on CEOP-R regimen TRIP on CEOP-R regimen
Clinical Trials
Ongoing Trials on CEOP-R regimen at Clinical Trials.gov Trial results on CEOP-R regimen Clinical Trials on CEOP-R regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on CEOP-R regimen NICE Guidance on CEOP-R regimen NHS PRODIGY Guidance FDA on CEOP-R regimen CDC on CEOP-R regimen
Books
Books on CEOP-R regimen
News
CEOP-R regimen in the news Be alerted to news on CEOP-R regimen News trends on CEOP-R regimen
Commentary
Blogs on CEOP-R regimen
Definitions
Definitions of CEOP-R regimen
Patient Resources / Community
Patient resources on CEOP-R regimen Discussion groups on CEOP-R regimen Patient Handouts on CEOP-R regimen Directions to Hospitals Treating CEOP-R regimen Risk calculators and risk factors for CEOP-R regimen
Healthcare Provider Resources
Symptoms of CEOP-R regimen Causes & Risk Factors for CEOP-R regimen Diagnostic studies for CEOP-R regimen Treatment of CEOP-R regimen
Continuing Medical Education (CME)
CME Programs on CEOP-R regimen
International
CEOP-R regimen en Espanol CEOP-R regimen en Francais
Business
CEOP-R regimen in the Marketplace Patents on CEOP-R regimen
Experimental / Informatics
List of terms related to CEOP-R regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen

Overview

CEOP-R regimen refers to an immunochemotherapy regimen consisting of rituximab, cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine (Oncovin) and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.

Regimen

R – Rituximab

C – Cyclophosphamide

H – Doxorubicin (Hydroxydaunomycin)

O – Vincristine (Oncovin)

P – Prednisone

Indications

• Diffuse large B-cell lymphoma, untreated
• Mantle cell lymphoma